TP53 and cancer: Several human Toll-like receptors (TLRs), whose signaling leads to NFκB activation [21], were identified as direct p53 target genes both in cancer cells and primary cells [22] and it was demonstrated that p53 and NFκB can cooperate in the activation of pro-inflammatory genes in primary human monocytes and macrophages [23].